Potential Probiotics for the Therapy of Metabolic Dysfunction-Associated Steatotic Liver Disease
<p id="p1">Metabolic dysfunction-associated steatotic liver disease (MASLD), a prevalent metabolic disorder globally, has presented an urgent need for effective therapeutic agents. The complex pathogenesis of MASLD and the failure of numerous clinical trials targeting this disease have prompted the...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1217839 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|